Tag: Choroidal neovascularization/drug therapy

Influence of repetitive intravitreal ranibizumab for neovascular age-related macular degeneration on retinal pigment epithelium and choroidal thickness

2017, No. 10, Clinical Science

Authors: Qi Hang,  Chen Changzheng,  Su Yu,  Yi Zuohuizi DOI: 10.3760/cma.j.issn.2095-0160.2017.10.012 Published 2017-10-10 Cite as Chin J Exp Ophthalmol, 2017,35(10): 909-913. Abstract                               [Download PDF] [Read Full Text] Background Intravitreal injection of ranibizumab (IVR) is one of the most effective therapies for neovascular age-related macular degeneration (nAMD). Understanding the influence […]

Paying attention to the prognosis guiding effects of CNV dynamic changes based-OCT angiography in neovascular age-related macular degeneration after antiangiogenic therapy

2018, No. 01, Editorial

Authors: Zhao Zhi,  Sun Xiaodong DOI: 10.3760/cma.j.issn.2095-0160.2018.01.001 Published 2018-01-10 Cite as Chin J Exp Ophthalmol, 2018,36(1): 1-4. Abstract                              [Download PDF] [Read Full Text] Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is a first line therapy for neovascular age-related macular degeneration (nAMD). However, how to predict […]